HALO
insider transactionsHALOZYME THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-51.6K
0 buy · 51.6K sell
Net value · 30d
-$3.5M
$0 in · $3.5M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
10
0 buy · 51.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 30d
-
Sell·S
Torley Helen KEY
PRESIDENT AND CEO · 10b5-1
$3.4M
50.0K sh · $67.40 avg · 9 lots
Own -6%
-
Sell·S
Director · 10b5-1
$107.6K
1.6K sh · $66.21
Own -4%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Torley Helen KEY 10b5-1 | Sell S | 50.0K9 lots | $3.4M |
| Jun 1, 2026 | Connaughton Bernadette 10b5-1 | Sell S | 1.6K | $107.6K |
Buy Sell Non-market (grant · exercise · gift)
About HALO insider trading
This page tracks insider transactions for HALOZYME THERAPEUTICS, INC. (HALO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.